Antimetastatic therapy for Liver cancer: Metformin, the widely used drug to treat NIDDM, inhibits metastatic hepatocellular carcinoma through up regulation of its target gene USP9X, 5/June/2014, 5.38 am

Antimetastatic therapy for Liver cancer: Metformin, the widely used drug to treat NIDDM, inhibits metastatic hepatocellular carcinoma through up regulation of its target gene USP9X, 5/June/2014, 5.38 am

Antimetastatic therapy for Liver cancer: Metformin, the widely used drug to treat NIDDM, inhibits metastatic hepatocellular carcinoma through up regulation of its target gene USP9X, 5/June/2014, 5.38 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan,  Antimetastatic therapy for Liver cancer: Metformin, the widely used drug to treat NIDDM, inhibits metastatic hepatocellular carcinoma through up regulation of its target gene USP9X, 5/June/2014, 5.38 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Share
Start Typing